Cas:1259489-95-6 tert-butyl 9-oxa-2-azaspiro[5.5]undecane-2-carboxylate manufacturer & supplier

We serve Chemical Name:tert-butyl 9-oxa-2-azaspiro[5.5]undecane-2-carboxylate CAS:1259489-95-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

tert-butyl 9-oxa-2-azaspiro[5.5]undecane-2-carboxylate

Chemical Name:tert-butyl 9-oxa-2-azaspiro[5.5]undecane-2-carboxylate
CAS.NO:1259489-95-6
Synonyms:9-Oxa-2-azaspiro[5.5]undecane-9-carboxylic acid tert-butyl ester
Molecular Formula:C14H25NO3
Molecular Weight:255.35300
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:38.77000
Exact Mass:255.18300
LogP:2.75200

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 9-Oxa-2-azaspiro[5.5]undecane-9-carboxylic acid tert-butyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,9-Oxa-2-azaspiro[5.5]undecane-9-carboxylic acid tert-butyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,9-Oxa-2-azaspiro[5.5]undecane-9-carboxylic acid tert-butyl ester Use and application,9-Oxa-2-azaspiro[5.5]undecane-9-carboxylic acid tert-butyl ester technical grade,usp/ep/jp grade.


Related News: We’ve been in the vaccine space for more than 20 years and the impact of [Covid-19] on our revenue was really minor, says Franco. We’re proud of what we have done, but when you produce tens of millions [of pieces] every day, Covid is just one of several businesses. 3-(aziridin-1-yl)-2,3-dihydrothiophene 1,1-dioxide manufacturers Alexion has been working to push Ultomiris through additional indications ahead of Soliris’ expected loss of exclusivity in 2025. 1-(8-Trimethylsilanylethynyl-naphthalen-1-yl)-prop-2-en-1-ol suppliers This commercial API license is incredibly important as it marks the next phase in our growth and enables us to support customers from concept to commercialization. We are now able to fill the gap in the market for small-scale commercial API requirements while maintaining our expertise in delivering early-stage programs.” N-(4-amino-6,6-dimethyl-1,6-dihydro-[1,3,5]triazin-2-yl)-O-(6-chloro-benzo[1,3]dioxin-8-ylmethyl)-hydroxylamine vendor & factory A thorough safety and risk analysis procedure should be administered at an appropriate time with documentation that adheres to the rules and regulations set forth by the regulatory authorities. ,Alexion has been working to push Ultomiris through additional indications ahead of Soliris’ expected loss of exclusivity in 2025.